Literature DB >> 8598181

Cortical benzodiazepine receptor changes are related to frequency of partial seizures: a positron emission tomography study.

I Savic1, E Svanborg, J O Thorell.   

Abstract

Measurements of benzodiazepine (BZD) receptor density with positron emission tomography (PET) are a promising method of identifying and localizing epileptogenic regions. We investigated whether the pattern of BZD receptor changes depends on seizure frequency, studying 19 patients with matching seizure semiology but different rates of seizure occurrence, using [11C]flumazenil as the ligand. All patients had partial epilepsy and normal magnetic resonance imaging (MRI) of the brain. The visually determined PET focus, characterized by reduced BZD receptor density, corresponded to the epileptogenic focus/seizure onset region in all patients. The degree of BZD receptor reduction showed a positive correlation with seizure frequency. Patients with daily seizures differed from those with fewer seizures in two aspects: (a) the degree and extent of BZD receptor reduction was more pronounced, and (b) BZD receptors were also reduced in the primary projection areas of the focus. Flumazenil-PET reliably identifies epileptogenic brain regions in patients with partial seizures. In addition, flumazenil-PET can distinguish patients with frequent seizures. The method therefore is not only suitable for noninvasive localization of the seizure focus, but also may provide a biochemical marker of epileptogenicity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8598181     DOI: 10.1111/j.1528-1157.1996.tb00019.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  6 in total

1.  Routine production of [(18)f]flumazenil from iodonium tosylate using a sample pretreatment method: a 2.5-year production report.

Authors:  Byung Seok Moon; Jun Hyung Park; Hong Jin Lee; Byung Chul Lee; Sang Eun Kim
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

2.  Focal decreases of cortical GABAA receptor binding remote from the primary seizure focus: what do they indicate?

Authors:  Csaba Juhász; Eishi Asano; Aashit Shah; Diane C Chugani; Carlos E A Batista; Otto Muzik; Sandeep Sood; Harry T Chugani
Journal:  Epilepsia       Date:  2008-07-14       Impact factor: 5.864

3.  Use of a standardized uptake value for parametric in vivo imaging of benzodiazepine receptor distribution on [11C]flumazenil brain PET.

Authors:  Masahito Tsukamoto; Chietsugu Katoh; Tohru Shiga; Tomohito Kaji; Yuji Kuge; Kunihiro Nakada; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-21       Impact factor: 9.236

4.  Seizure outcomes in relation to the extent of resection of the perifocal fluorodeoxyglucose and flumazenil PET abnormalities in anteromedial temporal lobectomy.

Authors:  Milo Stanišić; Christopher Coello; Jugoslav Ivanović; Arild Egge; Torsten Danfors; John Hald; Einar Heminghyt; Marjan Makki Mikkelsen; Bård Kronen Krossnes; Are Hugo Pripp; Pål Gunnar Larsson
Journal:  Acta Neurochir (Wien)       Date:  2015-09-08       Impact factor: 2.216

5.  Αlpha 5 subunit-containing GABAA receptors in temporal lobe epilepsy with normal MRI.

Authors:  Colm J McGinnity; Daniela A Riaño Barros; Rainer Hinz; James F Myers; Siti N Yaakub; Charlotte Thyssen; Rolf A Heckemann; Jane de Tisi; John S Duncan; Josemir W Sander; Anne Lingford-Hughes; Matthias J Koepp; Alexander Hammers
Journal:  Brain Commun       Date:  2021-01-07

6.  In vivo measurement of hippocampal GABAA/cBZR density with [18F]-flumazenil PET for the study of disease progression in an animal model of temporal lobe epilepsy.

Authors:  Lucy Vivash; Marie-Claude Gregoire; Viviane Bouilleret; Alexis Berard; Catriona Wimberley; David Binns; Peter Roselt; Andrew Katsifis; Damian E Myers; Rodney J Hicks; Terence J O'Brien; Stefanie Dedeurwaerdere
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.